Dr. Heidrun Flaadt Cervini

Biography

Heidrun Flaadt Cervini studied Biology at the University of Constance, where she also completed her PhD. She undertook postdoctoral studies supported by a Marie Curie Fellowship at the École Normale Supérieure in Paris. Following her academic training, she served as COO of Diagene, a spin-off company from the University of Basel, where she supported the completion of a significant capital round. Her interest in Technology Transfer led her to the Office of Technology Transfer (OTT) at the University of Basel in 2005, where she began to build a new OTT at EMPA Dübendorf, a position she held until the end of 2007. In 2008, she moved to Ticino to join her husband and received a mandate from Università della Svizzera italiana in Lugano to establish new Executive Programs in the field of Bio-MedTech Entrepreneurship. She developed and implemented programs such as BioBusiness, MedTech Business, and eHealth Business. Currently, Heidrun Flaadt serves as the director of the Center of Advanced Studies on Entrepreneurship in Biomedicine (CASE BioMed) at USI, contributing significantly to innovation in the healthcare sector. In 2021, she was awarded the Women Healthcare Innovation award presented by the Innovation Office of the University of Basel in collaboration with various organizations, recognizing her work in advancing entrepreneurship in biomedicine. In 2023, she became a member of the Advisory Board of Swiss Healthcare Startups.

Research Interests

Experience

Awards